Author:
Kim Hee J.,Jeon Beom S.,Jenner Peter
Reference355 articles.
1. (1970, 1970/06/15). PARKINSONISM: L-Dopa Goes Commercial. Chemical & Engineering News Archive. Retrieved 25, 48, from http://dx.doi.org/10.1021/cen-v048n025.p013.
2. (2002a). COMT inhibitors: Management of Parkinson's disease. Movement Disorders, 17(Suppl. 4), S45–S51.
3. (2002b). DA agonists—Ergot derivatives: Cabergoline: Management of Parkinson's disease. Movement Disorders, 17(Suppl. 4), S68–S71.
4. (2002c). DA agonists—Non-ergot derivatives: Ropinirole: Management of Parkinson's disease. Movement Disorders, 17(Suppl. 4), S98–S102.
5. (2015). AbbVie announces U.S. FDA approval of DUOPA™ (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations in patients with advanced Parkinson's disease. Retrieved 12 Sep, 2016, from https://news.abbvie.com/news/abbvie-announces-us-fda-approval-duopa-carbidopa-and-levodopa-enteral-suspension-for-treatment-motor-fluctuations-in-patients-with-advanced-parkinsons-disease.htm.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献